|
1
|
Steffen B, Müller-Tidow C, Schwäble J,
Berdel WE and Serve H: The molecular pathogenesis of acute myeloid
leukemia. Crit Rev Oncol Hematol. 56:195–221. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deschler B and Lübbert M: Acute myeloid
leukemia: Epidemiology and etiology. Cancer. 107:2099–2107. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou H, Beevers CS and Huang S: The
targets of curcumin. Curr Drug Targets. 12:332–347. 2011.
View Article : Google Scholar :
|
|
4
|
Aggarwal BB and Sung B: Pharmacological
basis for the role of curcumin in chronic diseases: An age-old
spice with modern targets. Trends Pharmacol Sci. 30:85–94. 2009.
View Article : Google Scholar
|
|
5
|
Sharma RA, Steward WP and Gescher AJ:
Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med
Biol. 595:453–470. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gandhy SU, Kim K, Larsen L, Rosengren RJ
and Safe S: Curcumin and synthetic analogs induce reactive oxygen
species and decreases specificity protein (Sp) transcription
factors by targeting microRNAs. BMC Cancer. 12:5642012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liao YF, Hung HC, Hour TC, Hsu PC, Kao MC,
Tsay GJ and Liu GY: Curcumin induces apoptosis through an ornithine
decarboxylase-dependent pathway in human promyelocytic leukemia
HL-60 cells. Life Sci. 82:367–375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ravindran J, Prasad S and Aggarwal BB:
Curcumin and cancer cells: How many ways can curry kill tumor cells
selectively? AAPS J. 11:495–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sabarinathan D, Mahalakshmi P and Vanisree
AJ: Naringenin, a flavanone inhibits the proliferation of
cerebrally implanted C6 glioma cells in rats. Chem Biol Interact.
189:26–36. 2011. View Article : Google Scholar
|
|
10
|
Ekambaram G, Rajendran P, Magesh V and
Sakthisekaran D: Naringenin reduces tumor size and weight lost in
N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis
in rats. Nutr Res. 28:106–112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin L, Jin L, Lu L, Lu X, Zhang C, Zhang F
and Liang W: Naringenin reduces lung metastasis in a breast cancer
resection model. Protein Cell. 2:507–516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ahamad MS, Siddiqui S, Jafri A, Ahmad S,
Afzal M and Arshad M: Induction of apoptosis and antiproliferative
activity of naringenin in human epidermoid carcinoma cell through
ROS generation and cell cycle arrest. PLoS One. 9:e1100032014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arul D and Subramanian P: Naringenin
(citrus flavonone) induces growth inhibition, cell cycle arrest and
apoptosis in human hepatocellular carcinoma cells. Pathol Oncol
Res. 19:763–770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shishodia S, Amin HM, Lai R and Aggarwal
BB: Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB
activation, induces G1/S arrest, suppresses proliferation, and
induces apoptosis in mantle cell lymphoma. Biochem Pharmacol.
70:700–713. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Zhang S, Geng JX and Hu XY: Curcumin
inhibits human non-small cell lung cancer A549 cell proliferation
through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J
Cancer Prev. 14:4599–4602. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mehta HJ, Patel V and Sadikot RT: Curcumin
and lung cancer - a review. Target Oncol. 9:295–310. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao A, Li Q, Yin P, Dong Y, Shi H, Wang L,
Ji G, Xie J and Wu D: Curcumin induces apoptosis in human gastric
carcinoma AGS cells and colon carcinoma HT-29 cells through
mitochondrial dysfunction and endoplasmic reticulum stress.
Apoptosis. 18:1391–1402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bill MA, Nicholas C, Mace TA, Etter JP, Li
C, Schwartz EB, Fuchs JR, Young GS, Lin L, Lin J, et al:
Structurally modified curcumin analogs inhibit STAT3
phosphorylation and promote apoptosis of human renal cell carcinoma
and melanoma cell lines. PLoS One. 7:e407242012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cai YY, Lin WP, Li AP and Xu JY: Combined
effects of curcumin and triptolide on an ovarian cancer cell line.
Asian Pac J Cancer Prev. 14:4267–4271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai XZ, Yin HT, Sun LF, Hu X, Zhou C, Zhou
Y, Zhang W, Huang XE and Li XC: Potential therapeutic efficacy of
curcumin in liver cancer. Asian Pac J Cancer Prev. 14:3855–3859.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du Q, Hu B, An HM, Shen KP, Xu L, Deng S
and Wei MM: Synergistic anticancer effects of curcumin and
resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncol Rep.
29:1851–1858. 2013.PubMed/NCBI
|
|
22
|
Mo N, Li ZQ, Li J and Cao YD: Curcumin
inhibits TGF-β1-induced MMP-9 and invasion through ERK and Smad
signaling in breast cancer MDA-MB-231 cells. Asian Pac J Cancer
Prev. 13:5709–5714. 2012. View Article : Google Scholar
|
|
23
|
Yang CW, Chang CL, Lee HC, Chi CW, Pan JP
and Yang WC: Curcumin induces the apoptosis of human monocytic
leukemia THP-1 cells via the activation of JNK/ERK pathways. BMC
Complement Altern Med. 12:222012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Geng QR, Wang L and Lu Y: Curcumin
potentiates antitumor activity of L-asparaginase via inhibition of
the AKT signaling pathway in acute lymphoblastic leukemia. Leuk
Lymphoma. 53:1376–1382. 2012. View Article : Google Scholar
|
|
25
|
Ke CS, Liu HS, Yen CH, Huang GC, Cheng HC,
Huang CY and Su CL: Curcumin-induced Aurora-A suppression not only
causes mitotic defect and cell cycle arrest but also alters
chemosensitivity to anticancer drugs. J Nutr Biochem. 25:526–539.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park JH, Jin CY, Lee BK, Kim GY, Choi YH
and Jeong YK: Naringenin induces apoptosis through downregulation
of Akt and caspase-3 activation in human leukemia THP-1 cells. Food
Chem Toxicol. 46:3684–3690. 2008. View Article : Google Scholar : PubMed/NCBI
|
